TempraMed Technologies Ltd. (VIVI:CC) | Stock Information | Vox Markets
Vox Markets

TempraMed Technologies Ltd.

VIVI:CC

Recent News

CompanyTitleDate
VIVITempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana2 hours ago
VIVITempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already Exceeding Full-Year 2025 Revenue4 days ago
VIVITempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in GreeceSep 1, 2026
VIVITempraMed Signs Definitive Five-Year Saudi Arabia Distribution Agreement for Private- Label VIVI CapAug 25, 2026
VIVITempraMed Announces Extension of Maccabi Healthcare Services AgreementAug 20, 2026
VIVITempraMed Executes Definitive Exclusive Distribution Agreement with TEM in Panama, Advancing Commercial Expansion Across Clinics and PharmaciesAug 18, 2026
VIVITempraMed Announces Strategic Partnership with Stealth Health, a Leading Telemedicine Platform for Longevity and WellnessAug 4, 2026
VIVITempraMed Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. InvestorsJul 30, 2026
VIVITempraMed Expands Institutional Healthcare Network with Meuhedet Health Services, a Leading HMO in Israel, Covering over 1 Million LivesJul 9, 2026
VIVITempraMed Signs LOI for Exclusive Distribution in Kuwait, Expanding Presence in High-Growth Gulf Region Healthcare MarketJul 6, 2026
VIVITempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B ChannelsJun 30, 2026
VIVITempraMed Signs Non-Binding LOI with National Distributor in Saudi ArabiaJun 29, 2026
VIVIVIVI monthly report May 2026Jun 4, 2026
VIVIVIVI form 10 IR VIVI June 2026Jun 4, 2026
VIVIVIVI TempraMed Signs Agreement for Exclusive Distribution Partnership in Brazil, One of the Largest Diabetes and Biologics Markets GloballyJun 4, 2026
VIVIVIVI TempraMed Featured on Dr. Phil Show in National US Broadcast Highlighting the Risk of Temperature Exposure for Insulin and Other MedicationsMay 22, 2026
VIVIVIVI TempraMed Announces Granted Indian Design Patent for VIVI Cap Smart ProductMay 14, 2026
VIVIVIVI Annual listing Summary Dec 31, 2025May 5, 2026
VIVIVIVI monthly report April 2026May 5, 2026
VIVIVIVI TempraMed Announces Continuance into OntarioApr 29, 2026
Showing 1 to 20 of 24 results

Overview

Classification

Sector Healthcare

Industry Medical Equipment & Supplies

Subindustry Surgical & Medical Apparatus

Financials